Mutations of several cancer driver genes such as BRCA, PIK3CA, ERBB2/ 3, and TP53 have frequently been reported in HBC, but rare mutations are still veiled due to the high heterogeneity of humans [41,42]. Here, TP53 is linked to cancer.